Cyclerion Therapeutics annual free cash flow
2018
2019
2020
2021
2022
Cyclerion Therapeutics Free Cash Flow (FCF) History (CYCN)
Cyclerion Therapeutics reported −$40.6M in free cash flow for fiscal 2022, a decrease of $4.1M from the previous fiscal year, with a free cash flow margin of −13673.74%.
View full Cyclerion Therapeutics company overviewCyclerion Therapeutics free cash flow by year
| Fiscal year | Period ended | Free cash flow | Change | Growth | FCF margin |
|---|---|---|---|---|---|
| 2022 | 2022-12-31 | −$40.6M | −$4.1M | — | −13673.74% |
| 2021 | 2021-12-31 | −$36.5M | $37.5M | — | −926.53% |
| 2020 | 2020-12-31 | −$74.0M | $35.1M | — | −3223.61% |
| 2019 | 2019-12-31 | −$109.1M | −$8.2M | — | −2420.75% |
| 2018 | 2018-12-31 | −$100.9M | — | — | — |
Cyclerion Therapeutics quarterly free cash flow
Q1.18
Q2.18
Q3.18
Q4.18
Q1.19
Q2.19
Q3.19
Q4.19
Q1.20
Q2.20
Q3.20
Q4.20
Q1.25
Q2.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Free cash flow | Change | YoY growth | FCF margin |
|---|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | −$1.4M | $12.6M | — | — |
| Q1 2026 | 2026-03-31 | −$1.2M | $13.8M | — | — |
| Q2 2025 | 2025-06-30 | −$503,000 | $13.8M | — | −540.86% |
| Q1 2025 | 2025-03-31 | −$968,000 | $29.6M | — | −1195.06% |
| Q4 2020 | 2020-12-31 | −$14.1M | $8.3M | — | −10583.46% |
| Q3 2020 | 2020-09-30 | −$15.1M | $9.4M | — | −3764.25% |
| Q2 2020 | 2020-06-30 | −$14.3M | $11.9M | — | −1908.68% |
| Q1 2020 | 2020-03-31 | −$30.6M | $5.5M | — | −3016.27% |
| Q4 2019 | 2019-12-31 | −$22.3M | $2.6M | — | — |
| Q3 2019 | 2019-09-30 | −$24.5M | $2.0M | — | −1750.00% |
| Q2 2019 | 2019-06-30 | −$26.2M | −$3.3M | — | −1610.32% |
| Q1 2019 | 2019-03-31 | −$36.1M | −$9.5M | — | — |
| Q4 2018 | 2018-12-31 | −$25.0M | — | — | — |
| Q3 2018 | 2018-09-30 | −$26.5M | — | — | — |
| Q2 2018 | 2018-06-30 | −$22.9M | — | — | — |
| Q1 2018 | 2018-03-31 | −$26.6M | — | — | — |
Cyclerion Therapeutics free cash flow growth trends
Cyclerion Therapeutics's latest reported quarter, Q2 2026, generated −$1.4M in free cash flow, an increase of $12.6M year over year.
About the metric
What free cash flow means
Free cash flow is the cash a company generates from operations after capital expenditures. Positive FCF can fund dividends, buybacks, debt repayment, or reinvestment; negative FCF means capital spending exceeded operating cash flow for that period.
Calculation and source
How free cash flow is calculated
TickerStat calculates free cash flow as SEC-reported operating cash flow minus capital expenditures. FCF margin equals free cash flow divided by revenue. Fiscal periods can differ from calendar years, so the tables include exact period-end dates.
Review Cyclerion Therapeutics filings at SEC.gov ↗